PortalPublikationenEwing sarcoma

Ewing sarcoma

Standard

Ewing sarcoma. / Eaton, Bree R; Claude, Line; Indelicato, Daniel J; Vatner, Ralph; Yeh, Brian; Schwarz, Rudolf; Laack, Nadia.

in: PEDIATR BLOOD CANCER, Jahrgang 68, Nr. S2, e28355, 05.2021.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung

Harvard

Eaton, BR, Claude, L, Indelicato, DJ, Vatner, R, Yeh, B, Schwarz, R & Laack, N 2021, 'Ewing sarcoma', PEDIATR BLOOD CANCER, Jg. 68, Nr. S2, e28355. https://doi.org/10.1002/pbc.28355

APA

Eaton, B. R., Claude, L., Indelicato, D. J., Vatner, R., Yeh, B., Schwarz, R., & Laack, N. (2021). Ewing sarcoma. PEDIATR BLOOD CANCER, 68(S2), [e28355]. https://doi.org/10.1002/pbc.28355

Vancouver

Eaton BR, Claude L, Indelicato DJ, Vatner R, Yeh B, Schwarz R et al. Ewing sarcoma. PEDIATR BLOOD CANCER. 2021 Mai;68(S2). e28355. https://doi.org/10.1002/pbc.28355

Bibtex

@article{8c778344d9c044c6aca7fda8dca71bcd,
title = "Ewing sarcoma",
abstract = "Ewing sarcoma is a rare tumor that requires complex multidisciplinary management. This report describes the general management and standard radiotherapy guidelines in both North America (Children's Oncology Group) and Europe (International Society of Pediatric Oncology). Standard treatment involves multiagent induction chemotherapy followed by local treatment with surgery, definitive radiation, or a combination of surgery and radiation followed by additional chemotherapy and consolidation local treatment to metastatic sites. The data supporting the role of chemotherapy, surgery, and radiation and specific radiation therapy guidelines are presented.",
keywords = "Bone Neoplasms/pathology, Child, Combined Modality Therapy, Humans, Prognosis, Sarcoma, Ewing/pathology, Survival Rate",
author = "Eaton, {Bree R} and Line Claude and Indelicato, {Daniel J} and Ralph Vatner and Brian Yeh and Rudolf Schwarz and Nadia Laack",
note = "{\textcopyright} 2021 Wiley Periodicals LLC.",
year = "2021",
month = may,
doi = "10.1002/pbc.28355",
language = "English",
volume = "68",
journal = "PEDIATR BLOOD CANCER",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "S2",

}

RIS

TY - JOUR

T1 - Ewing sarcoma

AU - Eaton, Bree R

AU - Claude, Line

AU - Indelicato, Daniel J

AU - Vatner, Ralph

AU - Yeh, Brian

AU - Schwarz, Rudolf

AU - Laack, Nadia

N1 - © 2021 Wiley Periodicals LLC.

PY - 2021/5

Y1 - 2021/5

N2 - Ewing sarcoma is a rare tumor that requires complex multidisciplinary management. This report describes the general management and standard radiotherapy guidelines in both North America (Children's Oncology Group) and Europe (International Society of Pediatric Oncology). Standard treatment involves multiagent induction chemotherapy followed by local treatment with surgery, definitive radiation, or a combination of surgery and radiation followed by additional chemotherapy and consolidation local treatment to metastatic sites. The data supporting the role of chemotherapy, surgery, and radiation and specific radiation therapy guidelines are presented.

AB - Ewing sarcoma is a rare tumor that requires complex multidisciplinary management. This report describes the general management and standard radiotherapy guidelines in both North America (Children's Oncology Group) and Europe (International Society of Pediatric Oncology). Standard treatment involves multiagent induction chemotherapy followed by local treatment with surgery, definitive radiation, or a combination of surgery and radiation followed by additional chemotherapy and consolidation local treatment to metastatic sites. The data supporting the role of chemotherapy, surgery, and radiation and specific radiation therapy guidelines are presented.

KW - Bone Neoplasms/pathology

KW - Child

KW - Combined Modality Therapy

KW - Humans

KW - Prognosis

KW - Sarcoma, Ewing/pathology

KW - Survival Rate

U2 - 10.1002/pbc.28355

DO - 10.1002/pbc.28355

M3 - SCORING: Review article

C2 - 33818887

VL - 68

JO - PEDIATR BLOOD CANCER

JF - PEDIATR BLOOD CANCER

SN - 1545-5009

IS - S2

M1 - e28355

ER -